152 related articles for article (PubMed ID: 24523454)
1. CMV infection and glioma, a highly controversial concept struggling in the clinical arena.
Wick W; Platten M
Neuro Oncol; 2014 Mar; 16(3):332-3. PubMed ID: 24523454
[No Abstract] [Full Text] [Related]
2. Does valganciclovir have a role in glioblastoma therapy?
Cobbs CS
Neuro Oncol; 2014 Mar; 16(3):330-1. PubMed ID: 24523453
[No Abstract] [Full Text] [Related]
3. Controversies in neuro-oncology: does valganciclovir have a role in the treatment of high-grade gliomas?
Wen PY
Neuro Oncol; 2014 Mar; 16(3):329. PubMed ID: 24523452
[No Abstract] [Full Text] [Related]
4. The legend of cytomegalovirus and glioblastoma lives on.
Weller M; Soffietti R; Brada M
Neuro Oncol; 2014 Jan; 16(1):166. PubMed ID: 24311642
[No Abstract] [Full Text] [Related]
5. Challenging cytomegalovirus data in glioblastoma.
Wick W; Wick A; Platten M
Neuro Oncol; 2014 Jan; 16(1):165. PubMed ID: 24353326
[No Abstract] [Full Text] [Related]
6. [Questionable effect of antiviral therapy in malignant brain tumors].
Kinhult S; Werlenius K; Hallbeck AL; Nyström PW; Männikkö V; Johansson M
Lakartidningen; 2014 Apr 29-May 13; 111(18-19):809. PubMed ID: 24855749
[No Abstract] [Full Text] [Related]
7. [Inconclusive data].
Kinhult S; Werlenius K; Hallbeck AL; Nyström PW; Männikkö V; Johansson M
Lakartidningen; 2014 Jul 2-15; 111(27-28):1192. PubMed ID: 25162111
[No Abstract] [Full Text] [Related]
8. VIGAS and beyond: the impact of HCMV-infection and its treatment in glioblastoma.
Ottenhausen M; Bodhinayake I; Schaefer PM; Boockvar JA
Neurosurgery; 2014 Apr; 74(4):N17-8. PubMed ID: 24642991
[No Abstract] [Full Text] [Related]
9. VIGAS and beyond: the impact of HCMV-infection and its treatment in glioblastoma.
Ottenhausen M; Bodhinayake I; Schaefer PM; Boockvar JA
Neurosurgery; 2014 Feb; 74(2):N23-4. PubMed ID: 24435151
[No Abstract] [Full Text] [Related]
10. Brain cancer. A viral link to glioblastoma?
Miller G
Science; 2009 Jan; 323(5910):30-1. PubMed ID: 19119195
[No Abstract] [Full Text] [Related]
11. Ganciclovir concentrations in the cerebral extracellular space after valganciclovir treatment; a case study.
Peredo I; Helldén A; Wolmer-Solberg N; Pohanka A; Stragliotto G; Rahbar A; Ståhle L; Bellander BM; Söderberg-Nauclér C
BMJ Case Rep; 2015 Dec; 2015():. PubMed ID: 26670887
[TBL] [Abstract][Full Text] [Related]
12. Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts.
Reusser P
Expert Opin Investig Drugs; 2001 Sep; 10(9):1745-53. PubMed ID: 11772283
[TBL] [Abstract][Full Text] [Related]
13. Valganciclovir: oral prevention and treatment of cytomegalovirus in the immunocompromised host.
Freeman RB
Expert Opin Pharmacother; 2004 Sep; 5(9):2007-16. PubMed ID: 15330737
[TBL] [Abstract][Full Text] [Related]
14. Immortal time bias in retrospective analysis: is there a survival benefit in patients with glioblastoma who received prolonged treatment of adjuvant valganciclovir?
Liu CJ; Hu YW
Int J Cancer; 2014 Jul; 135(1):250-1. PubMed ID: 24338590
[No Abstract] [Full Text] [Related]
15. [Valganciclovir maintenance therapy in AIDS: treatment failure due to the development of cytomegalovirus resistance to ganciclovir].
Couzigou C; Mazeron MC; Escaut L; Merad M; Vittecoq D
Med Mal Infect; 2005 Feb; 35(2):98-100. PubMed ID: 15780901
[No Abstract] [Full Text] [Related]
16. Survival in patients with glioblastoma receiving valganciclovir.
Söderberg-Nauclér C; Rahbar A; Stragliotto G
N Engl J Med; 2013 Sep; 369(10):985-6. PubMed ID: 24004141
[No Abstract] [Full Text] [Related]
17. Cytomegalovirus and brain tumor: epidemiology, biology and therapeutic aspects.
Cobbs CS
Curr Opin Oncol; 2013 Nov; 25(6):682-8. PubMed ID: 24097102
[TBL] [Abstract][Full Text] [Related]
18. Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: a randomized, double-blind, hypothesis-generating study.
Stragliotto G; Rahbar A; Solberg NW; Lilja A; Taher C; Orrego A; Bjurman B; Tammik C; Skarman P; Peredo I; Söderberg-Nauclér C
Int J Cancer; 2013 Sep; 133(5):1204-13. PubMed ID: 23404447
[TBL] [Abstract][Full Text] [Related]
19. Valganciclovir: a review of its use in the management of CMV infection and disease in immunocompromised patients.
Cvetković RS; Wellington K
Drugs; 2005; 65(6):859-78. PubMed ID: 15819597
[TBL] [Abstract][Full Text] [Related]
20. Valganciclovir treatment of primary cytomegalovirus pneumonitis in an immunocompetent adult.
Snape SE; Venkatesan P
BMJ Case Rep; 2011 Mar; 2011():. PubMed ID: 22707605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
